Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease

Area of Science:

• Genetics
• Biochemistry
• Animal Models

Background:

• The brindled mouse mutant (Mo(br)) serves as a critical animal model for human Menkes disease, a genetic copper deficiency disorder.
• Menkes disease is linked to mutations in the ATP7A gene, which encodes the copper-transporting P-type ATPase (MNK).
• The precise function of MNK and the nature of mutations affecting it are crucial for understanding copper metabolism and developing treatments.

Purpose of the Study:

• To elucidate the specific mutation in the brindled mouse model.
• To investigate the role of MNK in copper transport and cellular function.
• To provide insights into the molecular mechanisms underlying Menkes disease.

Main Methods:

• Genetic analysis of the brindled mouse to identify mutations in the ATP7A gene.
• Biochemical characterization of MNK protein in affected tissues.
• Western blot analysis to assess MNK protein levels.
• Immunohistochemistry to determine MNK localization within kidney tissues.

Main Results:

• A deletion of two amino acids was identified in a conserved region of MNK in the brindled mouse.
• Western blot revealed normal MNK levels in kidneys but absence in the liver of mutant mice.
• Immunohistochemistry showed MNK localized to proximal and distal tubules in both normal and mutant kidneys, suggesting a role in copper resorption.

Conclusions:

• The identified mutation in MNK provides a molecular basis for the copper deficiency observed in brindled mice.
• The findings suggest that the affected region of MNK may be involved in conformational changes crucial for P-type ATPase activity.
• MNK's localization in kidney tubules supports its role in copper reabsorption from urine, offering potential therapeutic targets for Menkes disease.